See more : Macromill, Inc. (MCCLF) Income Statement Analysis – Financial Results
Complete financial analysis of Srivichaivejvivat Public Company Limited (VIH.BK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Srivichaivejvivat Public Company Limited, a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Invesco Asia Trust plc (IAT.L) Income Statement Analysis – Financial Results
- McMillan Shakespeare Limited (MMS.AX) Income Statement Analysis – Financial Results
- Dongfang Electronics Co., Ltd. (000682.SZ) Income Statement Analysis – Financial Results
- Sintercom India Limited (SINTERCOM.NS) Income Statement Analysis – Financial Results
- Seco/Warwick S.A. (SWG.WA) Income Statement Analysis – Financial Results
Srivichaivejvivat Public Company Limited (VIH.BK)
About Srivichaivejvivat Public Company Limited
Srivichaivejvivat Public Company Limited, together with its subsidiaries, operates hospitals in Thailand. Its medical treatment covering every disease, such as orthopedic center, general surgery and include urology, brain center, general medicine clinic, cardiovascular medicine, nephrology, endocrinology, dermatology, neurology, dental center, physical rehabilitation, and plastic surgery, etc. It also operates a vocational school. The company was founded in 1987 and is based in Krathum Baen, Thailand.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.73B | 3.65B | 4.72B | 2.28B | 2.48B | 2.25B | 1.96B | 1.72B | 1.34B | 1.25B | 1.11B | 1.01B | 1.05B | 958.48M |
| Cost of Revenue | 2.06B | 2.36B | 2.69B | 1.73B | 1.88B | 1.71B | 1.53B | 1.29B | 1.01B | 938.59M | 845.96M | 795.47M | 787.30M | 728.48M |
| Gross Profit | 671.40M | 1.28B | 2.02B | 547.74M | 600.34M | 536.56M | 430.13M | 428.64M | 332.45M | 308.51M | 260.72M | 213.24M | 260.22M | 230.00M |
| Gross Profit Ratio | 24.56% | 35.22% | 42.91% | 24.07% | 24.20% | 23.88% | 21.92% | 24.94% | 24.73% | 24.74% | 23.56% | 21.14% | 24.84% | 24.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 264.16M | 283.95M | 365.72M | 255.00M | 278.84M | 244.77M | 215.08M | 196.76M | 183.82M | 173.38M | 163.01M | 167.25M | 168.34M | 121.98M |
| Selling & Marketing | 72.66M | 133.18M | 66.14M | 58.16M | 77.37M | 67.07M | 58.68M | 50.98M | 39.24M | 37.90M | 30.96M | 29.88M | 36.11M | 14.72M |
| SG&A | 336.82M | 417.13M | 431.85M | 313.16M | 356.21M | 311.83M | 273.76M | 247.74M | 223.07M | 211.28M | 193.97M | 197.13M | 204.45M | 136.70M |
| Other Expenses | -29.31M | -15.88M | -11.92M | -14.27M | 22.21M | 12.56M | 12.40M | 23.94M | 24.37M | 29.31M | 22.95M | 17.50M | 1.38M | 1.69M |
| Operating Expenses | 307.51M | 401.26M | 419.93M | 298.90M | 356.21M | 311.83M | 273.76M | 247.74M | 223.07M | 211.28M | 193.97M | 197.13M | 205.83M | 138.39M |
| Cost & Expenses | 2.37B | 2.76B | 3.11B | 2.03B | 2.24B | 2.02B | 1.81B | 1.54B | 1.23B | 1.15B | 1.04B | 992.60M | 993.13M | 866.86M |
| Interest Income | 0.00 | 11.01M | 15.68M | 21.01M | 20.44M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 9.89M | 11.01M | 15.68M | 21.01M | 20.44M | 20.68M | 18.97M | 15.74M | 6.93M | 7.61M | 11.28M | 16.69M | 19.41M | 18.43M |
| Depreciation & Amortization | 175.41M | 170.10M | 157.83M | 165.66M | 148.57M | 132.16M | 112.53M | 94.61M | 75.64M | 79.38M | 85.54M | 75.99M | 71.45M | 76.15M |
| EBITDA | 539.30M | 1.02B | 1.73B | 382.87M | 414.90M | 369.44M | 281.29M | 299.46M | 209.40M | 205.92M | 175.24M | 109.60M | 125.83M | 180.78M |
| EBITDA Ratio | 19.73% | 28.88% | 37.36% | 18.21% | 16.72% | 16.44% | 14.34% | 17.42% | 15.58% | 16.51% | 15.83% | 10.86% | 12.01% | 17.50% |
| Operating Income | 363.89M | 882.95M | 1.60B | 248.84M | 266.33M | 224.72M | 156.37M | 180.90M | 109.39M | 97.23M | 66.75M | 16.11M | 54.38M | 91.61M |
| Operating Income Ratio | 13.31% | 24.22% | 34.01% | 10.93% | 10.74% | 10.00% | 7.97% | 10.53% | 8.14% | 7.80% | 6.03% | 1.60% | 5.19% | 9.56% |
| Total Other Income/Expenses | -9.89M | -11.01M | -15.68M | -21.01M | -20.44M | -8.12M | -6.57M | 8.20M | 17.44M | 21.70M | 11.67M | -16.69M | 1.13M | -5.41M |
| Income Before Tax | 354.00M | 871.94M | 1.59B | 227.83M | 245.89M | 216.61M | 149.79M | 189.11M | 126.83M | 118.93M | 78.42M | 16.92M | 55.45M | 86.21M |
| Income Before Tax Ratio | 12.95% | 23.92% | 33.68% | 10.01% | 9.91% | 9.64% | 7.63% | 11.00% | 9.43% | 9.54% | 7.09% | 1.68% | 5.29% | 8.99% |
| Income Tax Expense | 69.16M | 172.70M | 328.77M | 40.98M | 45.47M | 39.49M | 24.11M | 35.64M | 25.19M | 23.53M | 16.78M | 8.99M | 15.28M | 25.92M |
| Net Income | 283.86M | 696.60M | 1.26B | 186.28M | 199.82M | 176.48M | 125.28M | 153.07M | 101.49M | 94.40M | 61.09M | 9.04M | 38.52M | 58.78M |
| Net Income Ratio | 10.38% | 19.11% | 26.61% | 8.19% | 8.05% | 7.86% | 6.38% | 8.91% | 7.55% | 7.57% | 5.52% | 0.90% | 3.68% | 6.13% |
| EPS | 0.50 | 1.22 | 2.20 | 0.33 | 0.35 | 0.31 | 0.22 | 0.27 | 0.18 | 0.17 | 0.10 | 0.03 | 0.10 | 0.19 |
| EPS Diluted | 0.50 | 1.22 | 2.20 | 0.33 | 0.35 | 0.31 | 0.22 | 0.27 | 0.18 | 0.17 | 0.10 | 0.03 | 0.10 | 0.19 |
| Weighted Avg Shares Out | 570.67M | 570.67M | 570.67M | 570.67M | 570.67M | 570.67M | 570.67M | 570.67M | 570.65M | 570.67M | 608.73M | 521.88M | 390.00M | 320.15M |
| Weighted Avg Shares Out (Dil) | 570.67M | 570.67M | 570.67M | 570.67M | 570.67M | 570.67M | 570.67M | 570.67M | 570.65M | 570.67M | 608.73M | 521.88M | 390.00M | 320.15M |
Source: https://incomestatements.info
Category: Stock Reports